Stromal cell therapy in treatment of radiation injury
View Patent ↗Methods are provided for treating, mitigating or protecting from radiation-induced injury using bone marrow stromal cells expanded in culture, adipose-tissue derived non-adherent stromal cells, or the culture supernatant thereof.
1. A method of treating, mitigating, or protecting from, an injury associated with exposure of a subject to >10 Gy radiation comprising administering to the subject before, during or after exposure of the subject to the radiation an amount of a supernatant obtained from a culture of adipose tissue-derived adherent and non-adherent stromal cells, effective to treat, mitigate or protect from an injury associated with exposure of a subject to radiation.
2. The method of claim 1 , wherein the radiation is gamma radiation.
3. The method of claim 1 , wherein the supernatant obtained from a culture of adipose-derived stromal cells is administered to the subject prior to the exposure of the subject to the radiation.
4. The method of claim 1 , wherein the supernatant obtained from a culture of adipose-derived stromal cells is administered to the subject subsequent to the exposure of the subject to the radiation.
5. The method of claim 1 , wherein the culture conditions comprise a basal medium.
6. The method of claim 1 , wherein the supernatant is administered by infusion into the subject.
7. The method of claim 1 , further comprising obtaining the adipose-derived stromal cells from the subject prior to culturing them.
8. The method of claim 1 , further comprising administering CD11b+ F480+ macrophages to the subject.
9. The method of claim 1 , wherein the supernatant is administered to the subject less than 72 hours after exposure to the radiation.
10. The method of claim 9 , wherein the supernatant is administered to the subject after 24 hours after the end of exposure, but less than 72 hours after the end of exposure, to the radiation.
11. A method of increasing the survival rate of a plurality of subjects exposed to an otherwise lethal dose of radiation comprising administering to each of the subjects before, during or after exposure of subjects to the otherwise lethal dose of radiation an amount of a supernatant obtained from a culture of adipose tissue-derived adherent and non-adherent stromal cells, effective to increase the survival rate of a plurality of subjects exposed to the otherwise lethal dose of radiation.
12. The method of claim 1 , wherein the injury is radiation-induced gastrointestinal syndrome (RIGS).